Retrospective cohort study analyzes mortality and survival in liver transplant recipients, indicating improved outcomes but persistent complication risks.
Objectives:The objective of the study was to analyze outcomes of a liver transplant program over 14 years and evaluate associations between patient characteristics, surgical factors, complications, and mortality.Methods: A retrospective cohort study was conducted at a transplant center, including patients from 2011 to 2025.Descriptive statistics, X 2 , Mann-Whitney U tests, and multivariate logistic regression were used to identify mortality predictors.Kaplan-Meier survival analysis was also performed. Results:The study included 109 liver transplant recipients.Rejection rates were higher among deceased patients (30.3% vs. 13.2%,p = 0.034).One-year survival improved from 63.3% (2011-2014) to 89.1% (2023-2025), with 100% rejection-free survival in the most recent cohort.Complications like multi-organ failure, bronchopneumonia, acute renal failure, ventilatory failure with coma, and leukoencephalopathy significantly increased mortality risk (odds ratio 4.27, p = 0.002).Conclusions: One-year survival has improved, with reduced rejection rates reflecting better post-transplant care.However, complications remain a major mortality risk.Shorter ischemia times indicate optimized surgical and logistical procedures.
No takes yet. Share an insight, caveat, or question.
Licht-Ardila et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: